Combined therapies increase side effects for patients with advanced breast cancer

Patients with advanced breast cancer who are treated with a combination of drugs that target specific molecules important for cancer development and also the hormones that are driving it are at increased risk of suffering adverse side effects. In new research presented at the Advanced Breast Cancer Fourth International Consensus Conference (ABC 4), researchers have … Continue reading Combined therapies increase side effects for patients with advanced breast cancer

Advertisements

´╗┐Combining new and old drugs improves survival for soft-tissue cancer patients

Adding a novel monoclonal antibody therapy to traditional chemotherapy increased median survival by nearly a year in patients with advanced sarcoma, a lethal soft-tissue cancer. Findings from a multicenter clinical trial of the combination therapy, led by researchers at Columbia University Medical Center and NewYork-Presbyterian, represent the first appreciable improvement in sarcoma outcomes in decades. … Continue reading ´╗┐Combining new and old drugs improves survival for soft-tissue cancer patients